| Original language | English (US) |
|---|---|
| Pages (from-to) | 29 |
| Number of pages | 1 |
| Journal | International Journal of Advances in Rheumatology |
| Volume | 9 |
| Issue number | 1 |
| State | Published - 2011 |
ASJC Scopus subject areas
- Rheumatology
Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study. Commentary
Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops
*Corresponding author for this work
Research output: Contribution to journal › Comment/debate › peer-review